Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-01

Clinical Trial Update: EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.

View source ↗

Summary

A multicenter real-world cohort study evaluating EptinezuMaB for migraine is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EptinezuMaB

Snippet

Sponsor: IRCCS San Raffaele Roma | Conditions: Migraine Disorders | Status: RECRUITING